Skip to main content

Table 2 Lipid profile in the SLE subjects and the control

From: Dysregulated serum lipid profile and its correlation to disease activity in young female adults diagnosed with systemic lupus erythematosus: a cross-sectional study

Parameter

SLE (n = 71)

Control (n = 71)

Reference

P

Total cholesterol (TC, mmol/L)

3.10 ± 0.08*

4.27 ± 0.10

3.10~5.69

0.02

Triglyceride (TG, mmol/L)

2.22 ± 0.06*

0.82 ± 0.03

0.40~1.60

< 0.01

HDL-C (mmol/L)

0.83 ± 0.04*

1.56 ± 0.05

0.83~1.96

0.02

LDL-C (mmol/L)

1.68 ± 0.05*

2.53 ± 0.04

2.07~3.10

< 0.01

VLDL-C (mmol/L)

0.78 ± 0.03*

0.28 ± 0.02

0.08~0.41

< 0.01

Apolipoprotein A (Apo A, g/L)

0.88 ± 0.03*

1.32 ± 0.04

1.00~2.00

< 0.01

Apolipoprotein B (Apo B, g/L)

0.63 ± 0.02*

0.92 ± 0.04

0.60~1.10

0.03

Apolipoprotein E (Apo E, mg/L)

38.57 ± 1.29

36.62 ± 1.14

27.00~45.00

0.08

  1. HDL-C High-density lipoprotein-cholesterol, LDL-C Low-density lipoprotein-cholesterol, VLDL-C Very low-density lipoprotein-cholesterol, and Data are mean ± SEM. Statistically significant difference between the SLE subjects and the control (*P < 0.05)
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X